Pipeline
Our pipeline opens many attractive opportunities for onvansertib
mCRPC / Abiraterone
Enrolling
mPDAC / Biomarker
Target Q1 '22
CMML / Single Agent
Development
Medulloblastoma / Combo w/ radiation
Development
Ovarian / PARP inhibitors
Development
Looking to partner with us?
Please send inquiries to [email protected]